Center-Authored Papers

Filters: Author is Eapen, Mary  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle J-H et al..  2017.  Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.. The Lancet. Haematology. Abstract
Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ et al..  2017.  Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.. Cancer. Abstract
Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS et al..  2011.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.. Blood. 118(2):282-8. Abstract
B
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract
C
Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME et al..  2015.  Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study. The Lancet Haematology. 2(9):e367-e375. Abstract
D
Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD.  2014.  Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.. Journal of comparative effectiveness research. 3(2):135-44. Abstract
Kim HT, Zhang M-J, Woolfrey AE, St Martin A, Chen J, Saber W, Perales M-A, Armand P, Eapen M.  2016.  Donor and recipient sex in allogeneic stem cell transplantation: what really matters.. Haematologica. Abstract
Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L et al..  2013.  Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.. Blood. 121(5):752-8. Abstract
E
Kekre N, Zhang Y, Zhang M-J, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C et al..  2017.  Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.. Haematologica. Abstract
Kollman C, Spellman SR, Zhang M-J, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, Dipersio JF, Fernandez-Viña M et al..  2015.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.. Blood. Abstract
Eckrich MJ, Ahn K-W, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M.  2014.  Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.. American journal of hematology. 89(2):125-9. Abstract
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK et al..  2012.  Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.. Blood. Abstract
F
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
H
Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, Dalissier A, Davis JH, Eames GM, Egeler MR et al..  2015.  Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.. British journal of haematology. 169(5):711-8. Abstract
Bonfim C, Ribeiro L, Nichele S, Loth G, Bitencourt M, Koliski A, Kuwahara C, Fabro AL, Pereira NF, Pilonetto D et al..  2016.  Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Ciurea SO, Zhang M-J, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM et al..  2015.  Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia.. Blood. Abstract
Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang M-J, Davies SM et al..  2010.  Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(2):223-30. Abstract
Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, Bajwa RPS, George B, Gupta V, Pasquini R, Schrezenmeier H et al..  2012.  HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(9):1401-6. Abstract
I
Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M et al..  2014.  Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.. Blood. 123(1):133-40. Abstract
Veys P, Wynn RF, Woo Ahn K, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC et al..  2012.  Impact of immune modulation with in vivo T cell depletion and myleoablative total body irradiation conditioning regimen on outcomes after unrelated donor transplantation for acute lymphoblastic leukemia in children.. Blood. Abstract
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
L
Eapen M, Woo Ahn K, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA et al..  2012.  Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED et al..  2016.  Long-term Survival, Organ Function and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(7):1257-63. Abstract
M
Bashey A, Zhang M-J, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M et al..  2017.  Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2017728428. Abstract